Apontis Pharma AG Cash Flow Quality Index
Apontis Pharma AG cash flow quality index. Apontis Pharma AG (APPH) has a Cash Flow Quality Index of -3.22x as of June 2025. Operating cash flow of €-1.94 Million is below net income of €603.75K, suggesting accrual-heavy earnings not yet converted to cash. See APPH FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Apontis Pharma AG (2022–2024)
Cash flow quality index of Apontis Pharma AG from 2022 to 2024. Historical Cash Flow Quality Index for Apontis Pharma AG across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore APPH operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Apontis Pharma AG Cash Flow Quality Index by Year (2022–2024)
Apontis Pharma AG cash flow quality index by year from 2022 to 2024. Year-by-year earnings quality comparison for Apontis Pharma AG. For the full cash flow conversion analysis, see how efficiently does Apontis Pharma AG generate cash.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -3.85x | €-2.90 Million | €753.57K | ▼ -193.9% |
| 2022 | 4.10x | €11.02 Million | €2.69 Million | — |